uMed enables healthcare providers to run patient research more efficiently through automating the clinical studies process
Umedeor has raised $12.5M in total funding. The most recent round was Series A. The last funding was announced in July 2023.
Umedeor's investors include AlbionVC, Playfair Capital, Delin Ventures, 11.2 Capital, PharmStars.
Umedeor is headquartered in London, United Kingdom.
uMed enables healthcare providers to run patient research more efficiently through automating the clinical studies process
Umedeor is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Umedeor — Funding & Investors." VCBacked, July 5, 2023, https://www.vcbacked.co/company/umedeor. Accessed September 14, 2026.
VCBacked. (2023). Umedeor — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/umedeor
{{cite web |title=Umedeor — Funding & Investors |url=https://www.vcbacked.co/company/umedeor |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated